Effect of Empagliflozin on the Metabolic Signature of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease

被引：145

作者：

Kappel, Ben A. ^{[1
]}

Lehrke, Michael ^{[1
]}

Schutt, Katharina ^{[1
]}

Artati, Anna ^{[2
]}

Adamski, Jerzy ^{[2
,3
,4
]}

Lebherz, Corinna ^{[1
]}

Marx, Nikolaus ^{[1
]}

机构：

[1] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Internal Med 1, Pauwelsstr 30, D-52074 Aachen, Germany

[2] German Res Ctr Environm Hlth, Helmholtz Zentrum Muchen, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany

[3] Tech Univ Munich, Life & Food Sci Ctr Weihenstephan, Inst Expt Genet, Freising Weihenstephan, Germany

[4] German Ctr Diabet Res, Neuherberg, Germany

来源：

CIRCULATION | 2017年 / 136卷 / 10期

关键词：

branched-chain amino acids; cardiovascular disease; empagliflozin; ketone bodies; metabolomics; SGTL2; inhibitors; type 2 diabetes mellitus; OUTCOMES;

D O I：

10.1161/CIRCULATIONAHA.117.029166

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：969 / 972

页数：4

共 5 条

[1] Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure [J].

Bedi, Kenneth C., Jr. ;

Snyder, Nathaniel W. ;

Brandimarto, Jeffrey ;

Aziz, Moez ;

Mesaros, Clementina ;

Worth, Andrew J. ;

Wang, Linda L. ;

Javaheri, Ali ;

Blair, Ian A. ;

Margulies, Kenneth B. ;

Rame, J. Eduardo .

CIRCULATION, 2016, 133 (08) :706-716

[2] CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis [J].

Ferrannini, Ele ;

Mark, Michael ;

Mayoux, Eric .

DIABETES CARE, 2016, 39 (07) :1108-1114

[3] Evolving Concepts of Myocardial Energy Metabolism More Than Just Fats and Carbohydrates [J].

Lopaschuk, Gary D. ;

Ussher, John R. .

CIRCULATION RESEARCH, 2016, 119 (11) :1173-1176

[4] Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis [J].

Mudaliar, Sunder ;

Alloju, Sindura ;

Henry, Robert R. .

DIABETES CARE, 2016, 39 (07) :1115-1122

[5] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].

Zinman, Bernard ;

Wanner, Christoph ;

Lachin, John M. ;

Fitchett, David ;

Bluhmki, Erich ;

Hantel, Stefan ;

Mattheus, Michaela ;

Devins, Theresa ;

Johansen, Odd Erik ;

Woerle, Hans J. ;

Broedl, Uli C. ;

Inzucchi, Silvio E. ;

Aizenberg, D. ;

Ulla, M. ;

Waitman, J. ;

De Loredo, L. ;

Farias, J. ;

Fideleff, H. ;

Lagrutta, M. ;

Maldonado, N. ;

Colombo, H. ;

Ferre Pacora, F. ;

Wasserman, A. ;

Maffei, L. ;

Lehman, R. ;

Selvanayagam, J. ;

d'Emden, M. ;

Fasching, P. ;

Paulweber, B. ;

Toplak, H. ;

Luger, A. ;

Drexel, H. ;

Prager, R. ;

Schnack, C. ;

Schernthaner, G. ;

Fliesser-Goerzer, E. ;

Kaser, S. ;

Scheen, A. ;

Van Gaal, L. ;

Hollanders, G. ;

Kockaerts, Y. ;

Capiau, L. ;

Chachati, A. ;

Persu, A. ;

Hermans, M. ;

Vantroyen, D. ;

Vercammen, C. ;

Van de Borne, P. ;

Mathieu, C. ;

Benhalima, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) :2117-2128

← 1 →